Paul J Strasma1, Simon Finfer2, Oliver Flower3, Brian Hipszer4, Mikhail Kosiborod5, Lewis Macken3, Marjolein Sechterberger6, Peter H J van der Voort7, J Hans DeVries6, Jeffrey I Joseph4. 1. GluMetrics, Inc, Irvine, CA, USA paul.strasma@gmail.com. 2. Royal North Shore Hospital, Sydney, Australia University of Sydney, Sydney, Australia. 3. Royal North Shore Hospital, Sydney, Australia. 4. Thomas Jefferson University Hospital, Philadelphia, PA, USA. 5. Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA. 6. Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. 7. Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands TIAS School for Business, Tilburg, Netherlands.
Abstract
BACKGROUND: Hyperglycemia and hypoglycemia are associated with adverse clinical outcomes in intensive care patients. In product development studies at 4 ICUs, the safety and performance of an intravascular continuous glucose monitoring (IV-CGM) system was evaluated in 70 postsurgical patients. METHODS: The GluCath System (GluMetrics, Inc) used a quenched chemical fluorescence mechanism to optically measure blood glucose when deployed via a radial artery catheter or directly into a peripheral vein. Periodic ultrasound assessed blood flow and thrombus formation. Patient glucose levels were managed according to the standard of care and existing protocols at each site. Reference blood samples were acquired hourly and compared against prospectively calibrated sensor results. RESULTS: In all, 63 arterial sensors and 9 venous sensors were deployed in 70 patients. Arterial sensors did not interfere with invasive blood pressure monitoring, sampling or other aspects of patient care. A majority of venous sensors (66%) exhibited thrombus on ultrasound. In all, 89.4% (1383/1547) of arterial and 72.2% (182/252) of venous measurements met ISO15197:2003 criteria (within 20%), and 72.7% (1124/1547) of arterial and 56.3% (142/252) of venous measurements met CLSI POCT 12-A3 criteria (within 12.5%). The aggregate mean absolute relative difference (MARD) between the sensors and the reference was 9.6% for arterial and 14.2% for venous sensors. CONCLUSIONS: The GluCath System exhibited acceptable accuracy when deployed in a radial artery for up to 48 hours in ICU patients after elective cardiac surgery. Accuracy of venous deployment was substantially lower with significant rates of intravascular thrombus observed using ultrasound.
BACKGROUND:Hyperglycemia and hypoglycemia are associated with adverse clinical outcomes in intensive care patients. In product development studies at 4 ICUs, the safety and performance of an intravascular continuous glucose monitoring (IV-CGM) system was evaluated in 70 postsurgical patients. METHODS: The GluCath System (GluMetrics, Inc) used a quenched chemical fluorescence mechanism to optically measure blood glucose when deployed via a radial artery catheter or directly into a peripheral vein. Periodic ultrasound assessed blood flow and thrombus formation. Patientglucose levels were managed according to the standard of care and existing protocols at each site. Reference blood samples were acquired hourly and compared against prospectively calibrated sensor results. RESULTS: In all, 63 arterial sensors and 9 venous sensors were deployed in 70 patients. Arterial sensors did not interfere with invasive blood pressure monitoring, sampling or other aspects of patient care. A majority of venous sensors (66%) exhibited thrombus on ultrasound. In all, 89.4% (1383/1547) of arterial and 72.2% (182/252) of venous measurements met ISO15197:2003 criteria (within 20%), and 72.7% (1124/1547) of arterial and 56.3% (142/252) of venous measurements met CLSI POCT 12-A3 criteria (within 12.5%). The aggregate mean absolute relative difference (MARD) between the sensors and the reference was 9.6% for arterial and 14.2% for venous sensors. CONCLUSIONS: The GluCath System exhibited acceptable accuracy when deployed in a radial artery for up to 48 hours in ICU patients after elective cardiac surgery. Accuracy of venous deployment was substantially lower with significant rates of intravascular thrombus observed using ultrasound.
Authors: R Scott Evans; Jamie H Sharp; Lorraine H Linford; James F Lloyd; Jacob S Tripp; Jason P Jones; Scott C Woller; Scott M Stevens; C Gregory Elliott; Lindell K Weaver Journal: Chest Date: 2010-10 Impact factor: 9.410
Authors: Harold L Lazar; Marie McDonnell; Stuart R Chipkin; Anthony P Furnary; Richard M Engelman; Archana R Sadhu; Charles R Bridges; Constance K Haan; Rolf Svedjeholm; Heinrich Taegtmeyer; Richard J Shemin Journal: Ann Thorac Surg Date: 2009-02 Impact factor: 4.330
Authors: Jeroen Hermanides; Robert J Bosman; Titia M Vriesendorp; Ron Dotsch; Frits R Rosendaal; Durk F Zandstra; Joost B L Hoekstra; J Hans DeVries Journal: Crit Care Med Date: 2010-06 Impact factor: 7.598
Authors: Judith Jacobi; Nicholas Bircher; James Krinsley; Michael Agus; Susan S Braithwaite; Clifford Deutschman; Amado X Freire; Douglas Geehan; Benjamin Kohl; Stanley A Nasraway; Mark Rigby; Karen Sands; Lynn Schallom; Beth Taylor; Guillermo Umpierrez; John Mazuski; Holger Schunemann Journal: Crit Care Med Date: 2012-12 Impact factor: 7.598
Authors: Simon Finfer; Bette Liu; Dean R Chittock; Robyn Norton; John A Myburgh; Colin McArthur; Imogen Mitchell; Denise Foster; Vinay Dhingra; William R Henderson; Juan J Ronco; Rinaldo Bellomo; Deborah Cook; Ellen McDonald; Peter Dodek; Paul C Hébert; Daren K Heyland; Bruce G Robinson Journal: N Engl J Med Date: 2012-09-20 Impact factor: 91.245
Authors: Oliver J Flower; Simon Bird; Lewis Macken; Naomi Hammond; Elizabeth Yarad; Frances Bass; Charles Fisher; Paul Strasma; Simon Finfer Journal: Crit Care Resusc Date: 2014-03 Impact factor: 2.159
Authors: Jean-Charles Preiser; J Geoffrey Chase; Roman Hovorka; Jeffrey I Joseph; James S Krinsley; Christophe De Block; Thomas Desaive; Luc Foubert; Pierre Kalfon; Ulrike Pielmeier; Tom Van Herpe; Jan Wernerman Journal: J Diabetes Sci Technol Date: 2016-11-01
Authors: Sybil A McAuley; Tri T Dang; Jodie C Horsburgh; Anubhuti Bansal; Glenn M Ward; Sarkis Aroyan; Alicia J Jenkins; Richard J MacIsaac; Rajiv V Shah; David N O'Neal Journal: J Diabetes Sci Technol Date: 2016-05-03
Authors: Sigrid C J van Steen; Saskia Rijkenberg; Jacqueline Limpens; Peter H J van der Voort; Jeroen Hermanides; J Hans DeVries Journal: Sensors (Basel) Date: 2017-01-14 Impact factor: 3.576